Zobrazeno 1 - 10
of 33
pro vyhledávání: '"O. V. Dzhenina"'
Publikováno v:
Амбулаторная хирургия, Vol 21, Iss 1, Pp 64-73 (2024)
This literature review analyzes relationships and correlations between obesity and chronic venous diseases. The search of scien tific publications was carried out in the Cochrane Library, PubMed, Medscape and Medline databases in accordance with the
Externí odkaz:
https://doaj.org/article/ceec4014e44b4fa7931880894d602cad
Autor:
V. Yu. Bogachev, B. V. Boldin, P. Yu. Turkin, O. V. Dzhenina, O. A. Alukhanyan, N. V. Bogacheva
Publikováno v:
Амбулаторная хирургия, Vol 20, Iss 2, Pp 44-52 (2023)
Introduction. The prevalence of phlebopathies varies from 15 to 31%. The QoL of patients with phlebopathies is impaired. Phlebotropic therapy is the main method for treating phlebopathies. Aim. Evaluation of the efficacy and safety of micronized puri
Externí odkaz:
https://doaj.org/article/8323a069fc8a4988a2e8b58cfdd68fa4
Publikováno v:
Амбулаторная хирургия, Vol 19, Iss 2, Pp 13-20 (2022)
Введение. SARS-CoV-2 сопровождается развитием дисфункции венозного эндотелия, которая может привести к развитию персистирующей флебопатии
Externí odkaz:
https://doaj.org/article/308d4de5cb51483d859329d7b5a7bcbe
Publikováno v:
Амбулаторная хирургия, Vol 18, Iss 1, Pp 13-23 (2021)
Phlebotropic therapy is an important component of the pathogenetic treatment of chronic venous insufficiency (CVI) of the lower extremities. Venoactive drugs, which have proven their effectiveness and safety in a variety of studies, are widely repres
Externí odkaz:
https://doaj.org/article/0072465de5174139b06e57008c675026
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 1-2, Pp 15-21 (2020)
Pharmacotherapy plays a key role in the treatment of chronic venous diseases and their complications. This category of patients traditionally uses a variety of phlebotropic drugs, the vast majority of which are of plant origin, introducing specific t
Externí odkaz:
https://doaj.org/article/c85aa17075f344888295b5f109ecaa82
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 3-4, Pp 19-33 (2019)
RETRACTED ARTICLEChronic venous disease (CVD) is the most common vascular pathology that has a significant negative effect on physical and psychological health outcomes, and requires high level of public spending on healthcare. Number of CVD risk fac
Externí odkaz:
https://doaj.org/article/90869b55f1814c41bdf3cd2cce646508
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 1-2, Pp 14-18 (2019)
Pregnancy is an important specific risk factor for the development of chronic vein diseases in women. In addition to the superficial veins of the lower limbs, transformation often affects the pelvic veins. The management of pregnant women with vulvar
Externí odkaz:
https://doaj.org/article/7493dbce486a45f4baa3404a9d1fc9ed
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 1-2, Pp 19-25 (2019)
RETRACTED ARTICLEThe article is devoted to Aescusan, a well-studied preparation that is traditionally used in clinical practice for the treatment of chronic diseases of veins, hemorrhoids, postoperative and post-traumatic edema. The main active subst
Externí odkaz:
https://doaj.org/article/9928bb05f97741238ca1252e39c396d9
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 3-4, Pp 12-21 (2018)
The 19th Annual Meeting of the European Venous Forum held in the city of Athens in 28-30 June 2018 presented the long-awaited updated guidelines for the diagnosis and treatment of chronic venous diseases (CVD), the full text of which can be found in
Externí odkaz:
https://doaj.org/article/eed586a4a7d7495093e8b047fb8dfe8b
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 1-2, Pp 26-31 (2018)
Chronic venous insufficiency (CVI) is the most common pathology of the peripheral vascular system. One of the main principles of conservative treatment for both small and complicated forms is pharmacotherapy with the use of venoactive drugs. The effe
Externí odkaz:
https://doaj.org/article/9c6281f468e9487a9de99ca219821f74